Role of matrix metalloproteinase-2 in the cardioprotective effect of ischaemic postconditioning

被引:28
作者
Donato, Martin [1 ,2 ]
D'Annunzio, Veronica [1 ,2 ]
Buchholz, Bruno [1 ,2 ]
Miksztowicz, Veronica [3 ]
Lorenzo Carrion, Cristina [1 ,2 ]
Valdez, Laura B. [4 ]
Zaobornyj, Tamara [4 ]
Schreier, Laura [3 ]
Wikinski, Regina [3 ]
Boveris, Alberto [4 ]
Berg, Gabriela [3 ]
Gelpi, Ricardo J. [1 ,2 ]
机构
[1] Univ Buenos Aires, Fac Med, Inst Cardiovasc Physiopathol, Buenos Aires, DF, Argentina
[2] Univ Buenos Aires, Dept Pathol, Fac Med, Buenos Aires, DF, Argentina
[3] Univ Buenos Aires, Lipids & Lipoprot Lab, Inst Physiopathol & Clin Biochem, Dept Clin Biochem,Fac Pharm & Biochem, Buenos Aires, DF, Argentina
[4] Univ Buenos Aires, Fac Pharm & Biochem, Lab Free Rad Biol, Buenos Aires, DF, Argentina
关键词
REPERFUSION INJURY; INFARCT SIZE; MYOCARDIAL INJURY; ACTIVATION; CONTRIBUTES; GENERATION; INHIBITION;
D O I
10.1113/expphysiol.2009.049874
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
The activation of matrix metalloproteinases (MMPs) contributes to myocardial injury at the onset of reperfusion; however, their role in ischaemic postconditioning is unknown. The aim of the present study was to examine the effects of ischaemic postconditioning on MMP activity in isolated rabbit hearts. The isolated rabbit hearts were subjected to 30 min of global ischaemia followed by 180 min of reperfusion (I/R group; n = 8). In the ischaemic postconditioning group (n = 8), a postconditioning protocol was performed (2 cycles of 30 s reperfusion-ischaemia). In other experiments, we added doxycycline, an MMP inhibitor, at 25 (n = 7) or 50 mu mol l(-1) (n = 8) during the first 2 min of reperfusion. Coronary effluent and left ventricular tissue were collected during pre-ischaemic conditions and at different times during the reperfusion period to measure MMP-2 activity and cardiac protein nitration. We evaluated ventricular function and infarct size. In the I/R group, infarct size was 32.1 +/- 5.2%; Postcon reduced infarct size to 9.5 +/- 3.8% (P < 0.05) and inhibited MMP-2 activity during reperfusion. The administration of doxycycline at 50 mu mol l(-1) inhibited MMP-2 activity and cardiac protein nitration and reduced the infarct size to 9.7 +/- 2.8% (P < 0.05). A lower dose of doxycycline (25 mu mol l(-1)) failed to inhibit MMP-2 activity and did not modify the infarct size. Our results strongly suggest that ischaemic postconditioning may exert part of its cardioprotective effects through the inhibition of MMP-2 activity.
引用
收藏
页码:274 / 281
页数:8
相关论文
共 22 条
[1]   BEHAVIOR OF DOXYCYCLINE IN TISSUES [J].
BLANCHARD, P ;
RUDHARDT, M ;
FABRE, J .
CHEMOTHERAPY, 1975, 21 :8-18
[2]   Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart [J].
Cheung, PY ;
Sawicki, G ;
Wozniak, M ;
Wang, WJ ;
Radomski, MW ;
Schulz, R .
CIRCULATION, 2000, 101 (15) :1833-1839
[3]  
Cohen MV, 2000, CIRCULATION, V102, P579
[4]   Rosuvastatin Given During Reperfusion Decreases Infarct Size and Inhibits Matrix Metalloproteinase-2 Activity in Normocholesterolemic and Hypercholesterolemic Rabbits [J].
D'Annunzio, Veronica ;
Donato, Martin ;
Erni, Lukas ;
Miksztowicz, Veronica ;
Buchholz, Bruno ;
Lorenzo Carrion, Cristina ;
Schreier, Laura ;
Wikinski, Regina ;
Gelpi, Ricardo J. ;
Berg, Gabriela ;
Basso, Nidia .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2009, 53 (02) :137-144
[5]   Ischemic postconditioning reduces infarct size by activation of A1 receptors and K+ATP channels in both normal and hypercholesterolemic rabbits [J].
Donato, Martin ;
D'Annunzio, Veronica ;
Berg, Gabriela ;
Gonzalez, German ;
Schreier, Laura ;
Morales, Celina ;
Wikinski, Regina L. W. ;
Gelpi, Ricardo J. .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2007, 49 (05) :287-292
[6]   Proteomic analysis of cardiac metabolic enzymes in asphyxiated newborn piglets [J].
Fert-Bober, Justyna ;
Sawicki, Grzegorz ;
Lopaschuk, Gary D. ;
Cheung, Po-Yin .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 2008, 318 (1-2) :13-21
[7]   Hyperlipidemia attenuates the infarct size-limiting effect of ischemic preconditioning: Role of matrix metalloproteinase-2 inhibition [J].
Giricz, Z ;
Lalu, MM ;
Csonka, C ;
Bencsik, P ;
Schulz, R ;
Ferdinandy, P .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 316 (01) :154-161
[8]   TETRACYCLINES INHIBIT CONNECTIVE-TISSUE BREAKDOWN - NEW THERAPEUTIC IMPLICATIONS FOR AN OLD FAMILY OF DRUGS [J].
GOLUB, LM ;
RAMAMURTHY, NS ;
MCNAMARA, TF ;
GREENWALD, RA ;
RIFKIN, BR .
CRITICAL REVIEWS IN ORAL BIOLOGY AND MEDICINE, 1991, 2 (03) :297-322
[9]   Preconditioning decreases ischemia/reperfusion-induced release and activation of matrix metalloproteinase-2 [J].
Lalu, MM ;
Csonka, C ;
Giricz, Z ;
Csont, T ;
Schulz, R ;
Ferdinandy, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 296 (04) :937-941
[10]   INHIBITION OF EPITHELIAL-CELL MATRIX METALLOPROTEINASES BY TETRACYCLINES [J].
NIP, LH ;
UITTO, VJ ;
GOLUB, LM .
JOURNAL OF PERIODONTAL RESEARCH, 1993, 28 (05) :379-385